Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... with high and in 64,8% of patients with very high cardiovascular risk. Conclusion. Addition of a ramipril ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... Aim. To compare efficacy of ramipril generic Hartil® (Egis) to original drug Tritace® in patients ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients ..."
 
Vol 7, No 4 (2011) USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, A. V. Rudakov, T. S. Zhupanova
"... and hydrochlorothiazide in patients with arterial hypertension (HT) 2-3 degree and high or very high cardiovascular risk ..."
 
Vol 8, No 4 (2012) RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS  similar documents
S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
"... Prevention Evaluation), были: 1) проверка гипотезы о том, что рамиприл улучшает способность тромбоцитов ..."
 
Vol 8, No 4 (2012) COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»  similar documents
D. V. Nebieridze
"... inhibitor, ramipril, on cardio- vascular events in high-risk patients. N Engl J Med 2000; 342: 145–53. 4 ..."
 
Vol 11, No 3 (2015) THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Just a small part of hypertensive patients is treated effectively despite the wide variety ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND SAFETY OF RAMIPRIL, MOLSIDOMINE AND THEIR COMBINATION IN PATIENTS WITH CHRONIC HEART FAILURE, WHICH COMPLICATED ISCHEMIC HEART DISEASE Abstract  similar documents
I. I. Sinitsina, V. A. Orlov, G. J. Zaharova
"... inhibitors. Patients were split in 3 groups: patients of the 1st group received ramipril, patients of the 2nd ..."
 
Vol 14, No 6 (2018) Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk Abstract  PDF (Eng)  similar documents
O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk
"... of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... ) in patients with previous Q-wave myocardial infarction (Q-MI) in outpatient period of rehabilitation ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
"... recent studies have shown that ACE inhibitors improve prognosis in patients with clinically proved ..."
 
Vol 5, No 1 (2009) EFFECT OF MORNING AND EVENING RAMIPRIL TAKING ON AMBULATORY BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. M. Gorbunov, E. J. Fedorova, A. D. Deev, E. V. Platonova, O. J. Isaikina
"... . Evening ramipril taking is effective and safe. It can be recommended to patients with insufficient night ..."
 
Vol 4, No 2 (2008) RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE Abstract  similar documents
A. I. Chesnikova, I. N. Koshenskaja, V. P. Terentyev, N. N. Mozhaeva, I. V. Bedareva, L. A. Lavrik, T. V. Zhertovsky
"... in the both groups of the patients. Ramipril contributed additional pulse BP and BP loading reduction ..."
 
Vol 3, No 4 (2007) RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Abstract  similar documents
I. V. Szirov, E. V. Malichenko
"... . Ramipril is the one of the most studied drug of this group recommended for patients after acute myocardial ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... in patients with arterial hypertension and chronic heart failure has extended recently. The study results ..."
 
Vol 5, No 2 (2009) CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL Abstract  similar documents
D. A. Napalkov, E. N. Golovenko
"... . Ramipril efficacy in ischemic heart disease prevention as well as ramipril positive effect on myocardium ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... Ramipril Efficacy) [26] эффективность применения другого ингибитора АПФ рамиприла была доказана у больных с ..."
 
Vol 4, No 3 (2008) COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva
"... . Patients were randomized in groups of ramipril or enalapril taken in addition to standard therapy. CHF ..."
 
Vol 13, No 2 (2017) STUDY OF THE PARAMETERS OF TOLERABILITY AND ADHERENCE TO THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION ON THE BACKGROUND OF TREATMENT WITH FIXED COMBINATION OF RAMIPRIL AND AMLODIPINE (ACCORDING TO THE RESULTS OF OBSERVATIONAL STUDY "GRANAT-2") Abstract  similar documents
S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zakharova, O. V. Lerman, A. A. Garganeyeva, T. A. Gomova, S. A. Drozdetsky, A. I. Chesnikova
"... and adherence to antihypertensive therapy in patients with hypertension and chronic obstructive pulmonary ..."
 
Vol 2, No 3 (2006) COMPARATIVE RESEARCH OF ENALAPRIL AND ATENOLOL ANTIHYPERTENSIVE EFFICACY IN HIGH RISK PATIENTS Abstract  similar documents
O. M. Moiseeva, S. V. Villevalde, I. V. Emelyanov, T. G. Ivanova
"... is very important in prevention of cardiovascular complications especially in high risk patients. ..."
 
Vol 4, No 1 (2008) EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” Abstract  similar documents
статья Редакционная
"... исследования DREAM (Deabetes REduction Assessment with ramipril and rosiglitazoneMedication), вызвавшегоширокий ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... in hypertensive men with high cardiovascular risk. Materials and methods. Hypertensive men (n=21) with high ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... studies. In high risk patients monotherapy with Enam (enalapril, Dr. Reddy’s) decreases blood pressure ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... into treatment subgroups A (ramipril) and B (valsartan). All patients had clinical examination, transthoracic ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
"... Investigators. Telmisartan, Ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 ..."
 
Vol 13, No 4 (2017) OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT Abstract  similar documents
I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova
"... with isolated MS, respectively. Conclusion. A high prevalence of the main risk factors in patients with gout ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..."
 
Vol 5, No 4 (2009) EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH RENOPARENCHYMAL ARTERIAL HYPERTENSION IN ACTUAL CLINICAL PRACTICE Abstract  similar documents
N. J. Borovkova, N. N. Borovkov, T. I. Maslov
"... Aim. To evaluate efficacy and safety of combined antihypertensive therapy based on ramipril ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... 1 – n=2975, the group 2 – n=2705. Active correction of IHD RF (high blood pressure ..."
 
Vol 6, No 4 (2010) RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
M. V. Ezhov
"... doses are presented. In these studies high dose atorvastatin therapy was used in patients with acute ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..."
 
Vol 5, No 4 (2009) CHANGE OF CARDIOVASCULAR RISK FACTORS AND QUALITY OF LIFE IN YOUNG HYPERTENSIVE PATIENTS AS A RESULT OF PREVENTIVE CONSULTATION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina
"... correction of the risk factors is effective method of BP control in young hypertensive patients. High ..."
 
Vol 13, No 2 (2017) TREATMENT CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN ELDERLY PATIENTS: PRACTICE OF N.I. PIROGOV CITY CLINICAL HOSPITAL №1 Abstract  similar documents
M. Yu. Gilyarov, M. O. Zheltoukhova, E. V. Konstantinova, M. D. Muksinova, L. S. Muradova, A. P. Nesterov, A. E. Udovichenko
"... . A high frequency of comorbidity in the elderly patients with ACS was observed; hypertension was the most ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... safety in patients with arterial hypertension (HT) in combination with ischemic heart disease (IHD ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... Aim. To study the opinion of doctors about the possibility of statins prescription to patients ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... complications in patients receiving antiplatelet therapy is presented. Indications for antiplatelet therapy ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... the possibility of improving adherence to therapy in high-risk hypertensive patients with dyslipidemia by means ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... observation of patients 75 years and older with very high thromboembolic risk (CHA2DS2-VASc – 4,5  points ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... for achieving lower concentrations of lowdensity lipoprotein cholesterol in patients with high and very high ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... ), proarrhythmic effect (I A и I C) and high risk of drug interactions. Disopyramide use should be avoided due ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... . Аmioadarone is not considered as the drug of choice in elderly patients because of the high risk of serious ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... Aim. To study the awareness and opinion of patients with atrial fibrillation (AF) about the stroke ..."
 
Vol 3, No 1 (2007) COMPARATIVE ANALYSIS OF SATISFACTION IN HOSPITAL TREATMENT AMONG CARDIOLOGICAL PATIENTS Abstract  similar documents
Y. G. Shvarts, E. A. Naumova, E. V. Tarasenko
"... Survey, which is noted for high representation of the data (analysis of 12680 patient questionnaires ..."
 
Vol 8, No 1 (2012) THE EFFICACY OF HIGH-DOSE SIMVASTATIN IN ACUTE PERIOD OF ISCHEMIC STROKE Abstract  similar documents
V. V. Yakusevich, A. Yu. Malygin, S. V. Lychenko, A. S. Petrochenko, A. V. Kabanov
"... , dynamics of neurological deficit and endothelial dysfunction in patients with the first-time ischemic ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... hospitalization in elderly outpatients. Material and methods. The total of 248 patients aged 60–85 years with CHF ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... prescribed to elderly patients. Review of clinical and pharmacoepidemiological studies allows us to conclude ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... treatment stages in patients at high and very high cardiovascular risk during 2011-2015. Material ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... Aim. To determine the most significant factors forming patient’s attitude to treatment and factors ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... guidelines for management of patients with high cardiovascular risk; 2) common perception that isolated ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... with statins and UDCA is effective and safe in patients with high cardiovascular risk and concomitant liver ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... therapy in high doses is discussed in patients with IHD and dyslipidemia. Atorvastatin in high doses ..."
 
Vol 11, No 6 (2015) The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, N. V. Romanova, Yu. F. Osmolovskaya, S. P. Golitsyn
"... of the XXI century, which are associated with high morbidity and mortality of patients. Common risk factors ..."
 
Vol 4, No 3 (2008) INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) Abstract  similar documents
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak
"... Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..."
 
Vol 10, No 4 (2014) THE EFFICACY OF ANTIHYPERTENSIVE THERAPY IN ELDERLY PATIENTS AND TREATMENT COMPLIANCE ANALYSIS Abstract  similar documents
V. E. Olejnikov, I. V. Eliseeva, Yu. A. Tomashevskaya, N. A. Borisova, S. S. Fadeeva
"... %) revealed a high risk of non-compliance. 26 of patients (52%) forgot to take medications, 25 patients (50 ..."
 
Vol 2, No 3 (2006) EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova
"... processes and endothelial function in elderly patients with ischemic heart disease (IHD). Material ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 7, No 6 (2011) EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP Abstract  similar documents
L. R. Mirzakhanova
"... Aim. To compare survival rate and quality of life in geriatric patients after coronary stenting ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... ). Material and methods. The evaluation of platelet function in 30 patients with ischemic heart disease ..."
 
Vol 7, No 1 (2011) INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN Abstract  similar documents
V. M. Gorbunov, E. Yu. Fedorova, A. D. Deev, O. Yu. Isaikina, V. G. Belolipetskaya, E. A. Zhabina
"... patients with stable HT (mean day-time BP>135/85 mm Hg) were included. Ambulatory BP monitoring (ABPM ..."
 
Vol 4, No 5 (2008) EFFECT OF AMLODIPINE AND OF NIFEDIPINE RETARD ON AUTONOMIC REGULATION OF HEART RATE IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. D. Golovanova, T. V. Osipova
"... and nifedipine retard, 40 mg/d) on heart rate variability (HRV) in elderly hypertensive patients with different ..."
 
Vol 12, No 2 (2016) THE ASSOCIATION OF DEPRESSION WITH C-REACTIVE PROTEIN (THE DATA OF ESSE-RF EPIDEMIOLOGICAL STUDY) Abstract  similar documents
S. E. Evstifeeva, S. A. Shalnova, A. D. Deev, V. A. Metelskaya, G. V. Artamonova, O. A. Belova, J. V. Zhernakova, A. Yu. Efanov, A. O. Konradi, N. V. Kulakova, O. P. Rotar, G. V. Tolparov, I. A. Trubacheva, A. A. Shabunova, S. A. Boytsov
"... patients. Results. The continuing association between elevated levels of depression (HADS-D ≥8+) and high ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..."
 
Vol 10, No 2 (2014) THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
L. V. Kremneva, O. V. Abaturova, S. V. Shalaev
"... Arterial hypertension (HT) in patients with metabolic syndrome has features (early damage ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... %) patients had a high risk of death according to the ESC criteria, and 51 (80%) — an intermediate risk. PE ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... randomized into two groups: the first group included 43 patients who received high-dose statin therapy ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... of patients at a high cardiovascular risk of atherosclerosis problems and the dynamics of these parameters ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
"... fibrillation) among them than among younger people. Elderly people have high risks of both thromboembolic ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... The high prevalence of arterial hypertension in association with high and very high cardiovascular ..."
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... particularities in IHD patients with different concomitant diseases. Nebivolol effects are compared ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... ) use in patients having appropriate indications according to current clinical guidelines and to study ..."
 
Vol 5, No 3 (2009) ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH MODERATE/HIGH CARDIOVASCULAR RISK DURING LISINOPRIL AND SIMVASTATIN TREATMENT Abstract  similar documents
V. N. Isakova, O. G. Garbuzova, E. V. Klinkova, E. V. Bandurko
"... with moderate/high cardiovascular risk receiving lisinopril and simvastatin. Material and methods. 20 patients ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... and microcirculatory vessels in patients with arterial hypertension (HT) of 1-2 degrees and high body mass/obesity ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... drug of simvastatin, Zocor, in patients with hyperlipidaemia in short-term study. Material and methods ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Achievement of lipid target plasma levels in patients of high cardiovascular risk: is medicine choice ..."
 
Vol 12, No 3 (2016) EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva
"... on endothelial function and vascular stiffness parameters in patients with arterial hypertension 1-2 degrees ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... is associated with high efficacy, greater patient adherence to treatment and a lower incidence ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... predictors of its effectiveness in patients with very high cardiovascular risk. Material and methods. 58 ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 5, No 5 (2009) ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS Abstract  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina
"... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS Abstract  similar documents
Y. A. Karpov, V. V. Buza
"... The proofs of necessity of active arterial hypertension (AH) treatment in elderly patients ..."
 
Vol 10, No 1 (2014) ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz
"... Aim. To study the subjective opinion of patients and doctors about their individual experiences ..."
 
Vol 3, No 3 (2007) MAXIMAL REDUCTION OF CARDIOVASCULAR COMPLICATIONS RISK – THE MAIN TASK OF MODERN THERAPY FOR HIGH RISK PATIENTS. RANDOMIZED STUDY ON COMPREHENSIVE CONTROL ON ARTERIAL HYPERTENSION AND DYSLIPIDAEMIA Abstract  similar documents
N. P. Kutishenko, V. V. Yakusevich, A. A. Seragzim, A. D. Deev, S. Y. Martsevich
"... Maximal reduction of cardiovascular complications risk – the main task of modern therapy for high ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... and methods. Women with high activity of RA (n=130) were examined. Women without rheumatic diseases (n=25 ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... and methods. A total of 291 female patients less than 60 years of age with a definite diagnosis of RA were ..."
 
Vol 7, No 6 (2011) COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES Abstract  similar documents
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk
"... ) and microalbuminuria (MAU) and to calculate cost-effectiveness ratio (CER). Material and methods. Patients (n=75 ..."
 
Vol 10, No 1 (2014) SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE) Abstract  similar documents
R. Eschalier, J.J.V. McMurray, K. Swedberg, D.J. Veldhuisen van, H. Krum, S.J. Pocock, H. Shi, J. Vincent, P. Rossignol, F. Zannad, B. Pitt
"... and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function. Analyses ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... -analyzes comparing ACEi and ARB effects on the life prognosis in patients of the high cardiovascular risk ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... clinical example of successful telmisartan application in patients with hypertension, high risk ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... Aim. To study the prevalence of high residual platelet reactivity (HRPR) during the dual ..."
 
Vol 12, No 4 (2016) New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) Abstract  similar documents
Article Editorial
 
Vol 10, No 1 (2014) TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS Abstract  similar documents
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta
"... . Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358 (15): 1547 ..."
 
1 - 100 of 1285 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)